Interim Director of HERU
- About
-
- Email Address
- g.scotland@abdn.ac.uk
- Telephone Number
- +44 (0)1224 437181
- School/Department
- School of Medicine, Medical Sciences and Nutrition
Biography
Graham is a Professor and leads the Assessment of Technologies theme in HERU. He joined HERU in 2004 and held a joint appointment between HERU and the Health Services Research Unit (HSRU) from 2012 to 2022. His current research interests span both model- and trial-based economic evaluation, with particular emphasis on the use decision analytic modelling alongside randomised controlled trials to maximise their value for informing health care decision making. Graham graduated from the University of Edinburgh in 1998 with BSc (Hons) in pharmacology, and following this undertook an MSc in Health Services and Public Health Research at the University of Aberdeen. After completing his MSc he worked at the Dugald Baird Centre for Research in Women's Health, University of Aberdeen, where he undertook research into economic aspects of maternal healthcare delivery in developing countries. Since his appointment in HERU he has gained over 19 years’ experience working in the area of health technology assessment. Graham also has an in interest in how the broader measures of value can incorporated in health technology assessment, and in 2012 completed a part-time PhD on methods for incorporating broader measures of value into economic evaluation in the area of reproductive healthcare.
- Publications
-
Page 5 of 9 Results 41 to 50 of 84
HEALTH: laparoscopic supracervical hysterectomy versus second-generation endometrial ablation for the treatment of heavy menstrual bleeding: study protocol for a randomised controlled trial
Trials, vol. 19, 63Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1186/s13063-017-2374-9
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/10005/1/HEALTH_laparoscopic_supracervical_hysterectomy_versus_second_generation_endometrial_ablation_for_the_treatment_of_heavy_menstrual_bleeding_study_protocol_for_a_randomised_controlled_trial.pdf
Teduglutide for treating short bowel syndrome
Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence. 142 pagesBooks and Reports: Commissioned ReportsA pragmatic group sequential, placebo-controlled, randomised trial to determine the effectiveness of glyceryl trinitrate for retained placenta (GOT-IT): a study protocol
BMJ Open, vol. 7, e017134Contributions to Journals: ArticlesWhy do health economists promote technology adoption rather than the search for efficiency? A proposal for a change in our approach to economic evaluation in health care
Medical Decision Making, vol. 37, no. 2, pp. 139-147Contributions to Journals: ArticlesEarly lens extraction with intraocular lens implantation for the treatment of primary angle closure glaucoma: An economic evaluation based on data from the EAGLE trial
BMJ Open, vol. 7, no. 1, e013254Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1136/bmjopen-2016-013254
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/8141/1/e013254.full_1_.pdf
Effectiveness of early lens extraction for the treatment of primary angle-closure glaucoma (EAGLE): a randomised controlled trial
The Lancet, vol. 388, no. 10052, pp. 1389-1397Contributions to Journals: ArticlesModelling the cost-effectiveness of adopting risk stratified approaches to extended screening intervals in the national diabetic retinopathy screening programme in Scotland
Diabetic Medicine, vol. 33, no. 7, pp. 886-895Contributions to Journals: ArticlesIs self-monitoring an effective option for people receiving long-term vitamin K antagonist therapy? A systematic review and economic evaluation
BMJ Open, vol. 5, no. 6, e007758Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1136/bmjopen-2015-007758
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/4684/1/Sharma_BMJOpen_2015.pdf
Assessment of diagnostic tests and the impact on decision making: self-monitoring of oral anticoagulation therapy: Oral presentation
Contributions to Conferences: Other ContributionsThe clinical effectiveness and cost-effectiveness of point-of-care tests (CoaguChek system, INRatio2 PT/INR monitor and ProTime Microcoagulation system) for the self-monitoring of the coagulation status of people receiving long-term vitamin K antagonist therapy, compared with standard UK practice: systematic review and economic evaluation
Health Technology Assessment, vol. 19, no. 48, pp. 1-172Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.3310/hta19480
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/8976/1/Sharma_2015.pdf